Association between adipoq +45t>G polymorphism and type 2 diabetes: A systematic review and meta-analysis

International Journal of Molecular Sciences

Volumn 16, Issue 1, 2015, Pages 704-723

  Fan, Yaofu ^a   Wang, Kun ^a   Xu, Shuhang ^a   Chen, Guofang ^a   Di, Hongjie ^a   Cao, Meng ^a   Liu, Chao ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

ADIPOQ; Meta analysis; References; Single nucleotide polymorphisms (SNPs); Type 2 diabetes mellitus

Indexed keywords

ADIPONECTIN; ADIPOQ PROTEIN, HUMAN;

ALLELE; ARTICLE; DNA BASE COMPOSITION; ETHNICITY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; GENOTYPE; HUMAN; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; SYSTEMATIC REVIEW; FACTUAL DATABASE; GENETICS; ODDS RATIO; PATHOLOGY; RISK FACTOR;

ADIPONECTIN; ALLELES; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; GENOTYPE; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84920275968     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16010704     Document Type: Article

References (77)

1. Matharoo, K.; Arora, P.; Bhanwer, A.J. Association of adiponectin (ADIPOQ) and sulphonylurea receptor (ABCC8) gene polymorphisms with Type 2 diabetes in North Indian population of Punjab. Gene 2013, 527, 228–234.
2. Abbasi, F.; Chu, J.W.; Lamendola, C.; McLaughlin, T.; Hayden, J.; Reaven, G.M.; Reaven, P.D. Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes 2004, 53, 585–590.
3. Kern, P.A.; di Gregorio, G.B.; Lu, T.; Rassouli, N.; Ranganathan, G. Adiponectin expression from human adipose tissue: Relation to obesity, insulin resistance, and tumor necrosis factor-α expression. Diabetes 2003, 52, 1779–1785.
4. Tschritter, O.; Fritsche, A.; Thamer, C.; Haap, M.; Shirkavand, F.; Rahe, S.; Staiger, H.; Maerker, E.; Häring, H.; Stumvoll, M. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2003, 52, 239–243.
5. Takahashi, M.; Arita, Y.; Yamagata, K.; Matsukawa, Y.; Okutomi, K.; Horie, M.; Shimomura, I.; Hotta, K.; Kuriyama, H.; Kihara, S.; et al. Genomic structure and mutations in adipose-specific gene, adiponectin. Int. J. Obes. Relat. Metab. Disord. 2000, 24, 861–868.
6. Wang, Y.; Zhang, D.; Liu, Y.; Yang, Y.; Zhao, T.; Xu, J.; Li, S.; Zhang, Z.; Feng, G.; He, L.; et al. Association study of the single nucleotide polymorphisms in adiponectin-associated genes with type 2 diabetes in Han Chinese. J. Genet. Genomics 2009, 36, 417–423.
7. Suriyaprom, K.; Phonrat, B.; Namjuntra, P.; Harnroongroj, T.; Tungtrongchitr, R. The –11377C>G adiponectin gene polymorphism alters the adiponectin concentration and the susceptibility to type 2 diabetes in Thais. Int. J. Vitam. Nutr. Res. 2010, 80, 216–224.
8. Gupta, V.; Khadqawat, R.; Nq, HK.; Kumar, S.; Aggarwal, A.; Rao, V.R.; Sachdeva, M.P. A validation study of type 2 diabetes-related variants of the TCF7L2, HHEX, KCNJ11, and ADIPOQ genes in one endogamous ethnic group of North India. Ann. Hum. Genet. 2010, 74, 361–368.
9. Mousavinasab, F.; Tahtinen, T.; Jokelainen, J.; Koskela, P.; Vanhala, M.; Oikarinen, J.; Keinänen-Kiukaanniemi, S.; Laakso, M. Common polymorphisms (single-nucleotide polymorphisms SNP+45 and SNP+276) of the adiponectin gene regulate serum adiponectin concentrations and blood pressure in young Finnish men. Mol. Genet. Metab. 2006, 87, 147–151.
10. Arikoglu, H.; Ozdemir, H.; Kaya, D.E.; Ipekci, S.H.; Arslan, A.; Kayis, S.A.; Gonen, M.S. The Adiponectin variants contribute to the genetic background of type 2 diabetes in Turkish population. Gene. 2014, 534, 10–16.
11. Peters, K.E.; Beilby, J.; Cadby, G.; Warrington, N.M.; Bruce, D.G.; Davis, W.A.; Davis, T.M.; Wiltshire, S.; Knuiman, M.; McQuillan, B.M.; et al. A comprehensive investigation of variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/R2), and their association with serum adiponectin, type 2 diabetes, insulin resistance and the metabolic syndrome. BMC. Med. Genet. 2013, 14, 15.
12. Chiodini, B.D.; Specchia, C.; Gori, F.; Barlera, S.; D’Orazio, A.; Pietri, S.; Crociati, L.; Nicolucci, A.; Franciosi, M.; Signorini, S.; et al. Adiponectin gene polymorphisms and their effect on the risk of myocardial infarction and type 2 diabetes: An association study in an Italian population. Ther. Adv. Cardiovasc. Dis. 2010, 4, 223–230.
13. Hara, K.; Boutin, P.; Mori, Y.; Tobe, K.; Dina, C.; Yasuda, K.; Yamauchi, T.; Otabe, S.; Okada, T.; Eto, K.; et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002, 51, 536–540.
14. Populaire, C.; Mori, Y.; Dina, C.; Vasseur, F.; Vaxillaire, M.; Kadowaki, T.; Froguel, P. Does the -11377 promoter variant of APM1 gene contribute to the genetic risk for type 2 diabetes mellitus in Japanese families? Diabetologia 2003, 46, 443–445.
15. Dong, Y.; Li, G.; Luo, T.H.; Wu, G.; Huang, W.; Luo, M. Relationship between adiponectin gene polymorphisms and type 2 diabetes. Acad. J. Shanghai Second. Med. Univ. 2004, 12, 008.
16. Xia, H.; Mo, Y.Z.; Bian, R.W. Correlation between single nucleotide polymorphism of adiponectin gene and type 2 diabetes in Chinese. Chin. J. Endocrinol. Metab. 2004, 20, 236–237.
17. Lee, Y.Y.; Lee, N.S.; Cho, Y.M.; Moon, M.K.; Jung, H.S.; Park, Y.J.; Park, H.J.; Youn, B.S.; Lee, H.K.; Park, K.S.; et al. Genetic association study of adiponectin polymorphisms with risk of type 2 diabetes mellitus in Korean population. Diabet. Med. 2005, 22, 569–575.
18. Wang, Z.X. Study on Serum Adiponectin Level and Its Gene Polymorphism in Different Glucose Tolerance Humans. Master’s Thesis, Hebei Medical University, Shijiazhuang, China, 10 March 2005.
19. Su, Q.J. Association of the T-G Polymorphism in Adiponectin (Exon 2) with Diabetes and Related Risk Factors. Master’s Thesis, Guangxi Medical University, Nanning, China, 25 May 2005.
20. Zhai, B.; Ye, L.; Liu, J.W. Interaction of adiponectin and peroxisome proliferator-activated receptor γ 2 gene polymorphisms and their relationship with type 2 diabetes in population from Beijing communities. Chin. J. Clin. Rehabil. 2006, 10, 28–31.
21. Li, L.L.; Kang, X.L.; Ran, X.J.; Wang, Y.; Wang, C.H.; Huang, L.; Ren, J.; Luo, X.; Mao, X.M. Associations between 45T/G polymorphism of the adiponectin gene and plasma adiponectin levels with type 2 diabetes. Clin. Exp. Pharmacol. Physiol. 2007, 34, 1287–1290.
22. Zhang, J. Correlation between Single Nucleotide Polymorphism (+45, 276) of Adiponectin Gene and Type 2 Diabetes in Xinjiang Uigur Population. Master’s Thesis, Shihezi University, Shihezi, China, 15 June 2007.
23. Wang, Y.; He, L.; Huang, C.L. Correlation of adiponectin gene polymorphism and type 2 diabetes Mellitusin Han Population of Guangdong. J. Trop. Med. 2007, 7, 651–653.
24. Wei, Y.L.; Huo, Z.H.; Zhao, W. The relationship of the adiponectin +45 nucleotide T/G polymorphism with insulin resistance, obesity and type 2 diabetes. Chin. J. Diabetes 2007, 15, 583–585.
25. Cheng, W.; Yi, H.Z.; Ma, X.W. Single nucleotide polymorphism of adiponectin gene 45 site in patientswith type 2 diabetes in the south of Henan province. J. Zhengzhou Univ. 2007, 42, 1145–1147.
26. Shi, X.H.; Jin, F.; Sun, L.; Li, H.; Wang, L.; Yang, Z. Association of the polymorphism of SNP+45 (T/G) in adiponectin gene with type 2 diabetes. J. Clin. Rehabil. Tissue Eng. Res. 2007, 11, 4941–4944.
27. Wang, S.F.; Zhao, J.J.; Jiang, Q. The correlation between adiponectin gene polymorphism and type 2 diabetes. Chin. J. Endocrinol. Metab. 2007, 23, 51–52.
28. Wu, W.J.; Bu, R.F.; Liu, G.P. Study on serum adiponectin level and SNP45 in adiponectin gene in type 2 diabetes patients with hypertriglyceridemia. Chin. J. Diabetes 2008, 16, 402–404.
29. Sun, H.; Gong, Z.C.; Yin, J.Y.; Liu, H.L.; Liu, Y.Z.; Guo, Z.W.; Zhou, H.H.; Wu, J.; Liu, Z.Q. The association of adiponectin allele 45T/G and –11377C/G polymorphisms with type 2 diabetes and rosiglitazone response in Chinese patients. Br. J. Clin. Pharmacol. 2008, 65, 917–926.
30. Kang, Z.; Sun, C.K.; Zhao, H.Z.; Sha, Y.; Yu, D.; Liu, D.; Yan, X.; Xue, Y. Correlation between polymorphism of adiponectin gene and type 2 diabetes mellitus in Bai and Han population at Daliarea. Chin. J. Diabetes 2008, 16, 718–720.
31. Chen, Q.Y.; Su, Q.J.; Tan, W.W. Association of the T–G polymorphism in adiponectin (exon 2) with diabetes in Zhuang people in Guangxi. J. Guangxi Med. Univ. 2008, 25, 821–824.
32. Wang, Y.; Wang, T.; Zhong, H.T. An association research of adiponectin gene SNP45 T/G polymorphism and type 2 diabetes mellitus. Prog. Mod. Biomed. 2008, 8, 84–86.
33. Hao, J.M.; Diao, Z.H.; Liu, J.X. Correlation between single nucleotide polymorphism of adiponectin gene and type 2 diabetes in Han population of Hainan. Hainan Med. J. 2009, 20, 1–3.
34. Zhou, Q.; Yang, J.; Luo, M.S. Research on adiponectin’s single nucleotide polymorphism (SNP+45) site expression in type 2 diabetes mellitus. Int. J. Lab. Med. 2009, 30, 105–107.
35. Ye, H.; Zhuang, J. Association research of adiponectin gene T45G polymorphism and type 2 diabetes mellitusin Han Chinese. Pharm. Care. Res. 2009, 9, 158–160. (In Chinese)
36. Wang, Y.X.; Zhao, L.; Yu, S.G. Correlation of adiponectin gene polymorphism and type 2 diabetes mellitus. Shandong Med. J. 2010, 50, 1–2.
37. Wang, B.; Wang, C.; Wei, D.; Zhang, J.; He, H.; Ma, M.; Li, X.; Pan, L.; Xue, F.; Jonasson, J.M.; et al. An association study of SNP +45T>G of the ADIPOQ gene with type 2 diabetes in Yi and Han people in China. Int. J. Vitam. Nutr. Res. 2011, 81, 392–397.
38. He, H.J.; Wei, D.Y.; Wang, C.X. Association between single nucleotide polymorphism of adiponectin gene and type 2 diabetes in Han people in Liangshan, Sichuan province. Chin. J. Public Health 2012, 28, 302–304.
39. Kang, X.L.; Kang, X.L.; He, C.H. Correlation of 45T/G polymorphism adiponectin gene with type 2 diabetes in Kazaks of Xinjiang. J. China Med. Univ. 2012, 41, 454–457.
40. Nv, Y.; Ye, S.D.; Hu, H.L. The association of between the polymorphism of the adiponectin gene rs2241766 and rs1501299 and the metabolic traits of type 2 diabetes in Han Chinese. Chin. J. Clin. Healthc. 2012, 15, 337–339.
41. Kang, Z.; Su, H.; Zhang, Y. Genetic association analysis of the adiponectin polymorphisms in type 2 diabetes of Bai nationality at Dali area. Lab. Med. Clin. 2013, 10, 3122–3124.
42. Menzaghi, C.; Ercolino, T.; Di Paola, R.; Berg, A.H.; Warram, J.H.; Scherer, P.E.; Trischitta, V.; Doria, A. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002, 51, 2306–2312.
43. Fumeron, F.; Aubert, R.; Siddig, A.; Betoulle, D.; Péan, F.; Hadjadj, S.; Tichet, J.; Wilpart, E.; Chesnier, MC.; Balkau, B.; et al. Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: The epidemiologic data on the insulin resistance syndrome prospective study. Diabetes. 2004, 53, 1150–1157.
44. Ukkola, O.; Santaniemi, M.; Rankinen, T.; Leon, A.S.; Skinner, J.S.; Wilmore, J.H.; Rao, D.C.; Bergman, R.; Kesäniemi, Y.A.; Bouchard, C. Adiponectin polymorphisms, adiposity and insulin metabolism: HERITAGE family study and Oulu diabetic study. Ann. Med. 2005, 37, 141–150.
45. González-Sánchez, J.L.; Zabena, C.A.; Martínez-Larrad, M.T.; Fernández-Pérez, C.; Pérez-Barba, M.; Laakso, M.; Serrano-Ríos, M. An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance. Obes. Res. 2005, 13, 807–812.
46. Nannipieri, M.; Posadas, R.; Bonotti, A.; Williams, K.; Gonzalez-Villalpando, C.; Stern, M.P.; Ferrannini, E. Polymorphism of the 3'-untranslated region of the leptin receptor gene, but not the adiponectin SNP45 polymorphism, predicts type 2 diabetes. Diabetes Care. 2006, 29, 2509–2511.
47. Schwarz, P.E.; Govindarajalu, S.; Towers, W.; Schwanebeck, U.; Fischer, S.; Vasseur, F.; Bornstein, S.R.; Schulze, J. Haplotypes in the promoter region of the ADIPOQ gene are associated with increased diabetes risk in a German Caucasian population. Horm. Metab. Res. 2006, 38, 447–451.
48. Gable, D.R.; Matin, J.; Whittall, R.; Cakmak, H.; Li, K.W.; Cooper, J.; Miller, G.J.; Humphries, S.E.; HIFMECH investigators. Common adiponectin gene variants show different effects on risk of cardiovascular disease and type 2 diabetesin European subjects. Ann. Hum. Genet. 2007, 71, 453–466.
49. Potapov, V.A.; Chistiakov, D.A.; Dubinina, A.; Shamkhalova, M.S.; Shestakova, M.V.; Nosikov, V.V. Adiponectin andadiponectin receptor gene variants in relation to type 2 diabetes and insulin resistance related phenotypes. Rev. Diabet. Stud. 2008, 5, 28–37.
50. Szopa, M.; Malczewska-Malec, M.; Kiec-Wilk, B.; Skupien, J.; Wolkow, P.; Malecki, M.T.; Sieradzki, J. Variants of the adiponectin gene and type 2 diabetes in a Polish population. Acta Diabetol. 2009, 46, 317–322.
51. Mohammadzadeh, G.; Zarghami, N. Associations between single nucleotide polymorphisms of the adiponectin gene, serum adiponectin levels and increased risk of type 2 diabetes mellitus in Iranian obese individuals. Scand. J. Clin. Lab. Investig. 2009, 69, 764–771.
52. Vendramini, M.F.; Pereira, A.C.; Ferreira, S.R.; Kasamatsu, T.S.; Moisés, R.S.; Japanese Brazilian Diabetes Study Group. Association of genetic variants in the adiponectin encoding gene (ADIPOQ) with type 2 diabetes in Japanese Brazilians. J. Diabetes Complicat. 2010, 24, 115–120.
53. Tabatabaei-Malazy, O.; Hasani-Ranjbar, S.; Amoli, M.M.; Heshmat, R.; Sajadi, M.; Derakhshan, R.; Amiri, P.; Namakchian, M.; Rezazadeh, E.; Tavakkoly-Bazzaz, J.; et al. Genderspecific differences in the association of adiponectin gene polymorphisms with body mass index. Rev. Diabet. Stud. 2010, 7, 241–246.
54. Al-Daghri, N.M.; Al-Attas, O.S.; Alokail, M.S.; Alkharfy, K.M.; Hussain, T.; Yakout, S.; Vinodson, B.; Sabico, S. Adiponectin gene polymorphisms (T45G and G276T), adiponectin levels and risk formetabolic diseases in an Arab population. Gene 2012, 493, 142–147.
55. Vionnet, N.; Hani, E.H.; Dupont, S.; Gallina, S.; Francke, S.; Dotte, S.; de Matos, F.; Durand, E.; Leprêtre, F.; Lecoeur, C.; et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: Evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21–q24. Am. J. Genet. 2000, 67, 1470–1480.
56. Mori, Y.; Otabe, S.; Dina, C.; Yasuda, K.; Populaire, C.; Lecoeur, C.; Vatin, V.; Durand, E.; Hara, K.; Okada, T.; et al. Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p. Diabetes 2002, 51, 1247–1255.
57. Kissebah, A.H.; Sonnenberg, G.E.; Myklebust, J.; Goldstein, M.; Broman, K.; James, R.G.; Marks, J.A.; Krakower, G.R.; Jacob, H.J.; Weber, J.; et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc. Natl. Acad. Sci. USA 2000, 97, 14478–14483.
58. Borges, A.P.; Guidoni, C.M.; Freitas, O.D.; Pereira, L.R. Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service. Arg. Bras. Endocrinol. Metabol. 2011, 55, 686–691.
59. Lin, Y.; Sun, Z. Current views on type 2 diabetes. J. Endocrinol. 2010, 204, 1–11.
60. Gong, M.; Long, J.; Liu, Q.; Deng, H.C. Association of the ADIPOQ rs17360539 and rs266729 polymorphisms with type 2 diabetes: A meta-analysis. Mol. Cell. Endocrinol. 2010, 325, 78–83.
61. Han, L.Y.; Wu, Q.H.; Jiao, M.L.; Kumar, S.; Aggarwal, A.; Rao, V.R.; Sachdeva, M.P. Associations between single-nucleotide polymorphisms (+45T>G, +276G>T, –11377C>G, –11391G>A) of adiponectin gene and type 2 diabetes mellitus: A systematic review and meta-analysis. Diabetologia 2011, 54, 2303–2314.
62. Menzaghi, C.; Trischitta, V.; Doria, A. Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes 2007, 56, 1198–1209.
63. Li, Y.; Li, X.; Shi, L.; Yang, M.; Yang, Y.; Tao, W.; Shi, L.; Xiong, Y.; Zhang, Y.; Yao, Y. Association of adiponectin SNP+45 and SNP+276 with type 2 diabetes in Han Chinese populations: A meta-Analysis of 26 case-control studies. PLoS One 2011, 6, e19686.
64. Thompson, S.G. Why sources of heterogeneity in meta-analysis should be investigated. BMJ 1994, 309, 1351–1355.
65. Munafò, M.R.; Flint, J. Meta-analysis of genetic association studies. Trends Genet. 2004, 20, 439–444.
66. Nair, M. Diabetes mellitus, part 1: Physiology and complications. Br. J. Nurs. 2007, 16, 184–188.
67. Liao, N.; Xie, Z.K.; Huang, J.; Xie, Z.F. Association between the ghrelin Leu72Met polymorphism and type 2 diabetes risk: A meta-analysis. Gene 2013, 517, 179–183.
68. Kadowaki, T.; Yamauchi, T.; Kubota, N.; Hara, K.; Ueki, K.; Tobe, K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Investig. 2006, 116, 1784–1792.
69. Xita, N.; Tsatsoulis, A. Adiponectin in diabetes mellitus. Curr. Med. Chem. 2012, 19, 5451–5458.
70. Heidemann, C.; Sun, Q.; van Dam, R.M.; Meigs, J.B.; Zhang, C.; Tworoger, S.S.; Mantzoros, C.; Hu, F.B. Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann. Intern. Med. 2008, 149, 307–316.
71. Von Eynatten, M.; Humpert, P.M.; Bluemm, A.; Lepper, P.M.; Hamann, A.; Allolio, B.; Nawroth, P.P.; Bierhaus, A.; Dugi, K.A. High-molecular weight adiponectin is independently associated with the extent of coronary artery disease in men. Atherosclerosis 2008, 199, 123–128.
72. Seino, Y.; Hirose, H.; Saito, I.; Itoh, H. High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome: A population-based 6-year follow-up study in Japanese men. Metabolism 2009, 58, 355–360.
73. Fasshauer, M.; Klein, J.; Neumann, S.; Eszlinger, M.; Paschke, R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2002, 290, 1084–1089.
74. Koerner, A.; Kratzsch, J.; Kiess, W. Adipocytokines: Leptin—the classical, resistin—the controversical, adiponectin—the promising, and more to come. Best Pract. Res. Clin. Endocrinol. Metab. 2005, 19, 525–546.
75. Cochran, W.G. The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics 1968, 24, 295–313.
76. DerSimonian, R.; Laird, N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7, 177–188.
77. Mantel, N.; Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22, 719–748.